|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Loans | ||||||||||||||||||||
| Less: Allowance for credit losses | ||||||||||||||||||||
| Net loans | ||||||||||||||||||||
| Securities available-for-sale, fair value (amortized cost $1,137,072 and $1,041,188, respectively) | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Interest bearing deposits | ||||||||||||||||||||
| Restricted equity securities | ||||||||||||||||||||
| Federal funds sold | ||||||||||||||||||||
| Total earning assets | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Bank premises and equipment, net | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Deferred income tax asset | ||||||||||||||||||||
| Bank owned life insurance | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Other real estate | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Shareholders’ Equity | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Noninterest-bearing | ||||||||||||||||||||
| Interest bearing | ||||||||||||||||||||
| Savings and money market accounts | ||||||||||||||||||||
| Time | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Accrued interest payable and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ equity: | ||||||||||||||||||||
| Common stock, $2.00 par value; authorized 50,000,000 shares, issued and outstanding 12,291,843 and 12,145,641 shares, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Noncontrolling interest in consolidated subsidiary | ||||||||||||||||||||
| Accumulated other comprehensive losses, net of taxes of $22,005 and $19,519 respectively | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
Loading...
